vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and Sezzle Inc. (SEZL). Click either name above to swap in a different company.

Sezzle Inc. is the larger business by last-quarter revenue ($78.2M vs $45.1M, roughly 1.7× Amarin Corp plc). Sezzle Inc. runs the higher net margin — 54.6% vs -23.3%, a 77.9% gap on every dollar of revenue. On growth, Sezzle Inc. posted the faster year-over-year revenue change (61.6% vs 7.0%). Over the past eight quarters, Sezzle Inc.'s revenue compounded faster (76.0% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Sezzle is a publicly traded financial technology company headquartered in Minneapolis, U.S, with operations in the United States and Canada. The company provides an alternative payment platform offering interest-free installment plans at selected online stores. As of June 2021, the Sezzle platform had over 10 million user sign-ups and over 48,000 participating merchants.

AMRN vs SEZL — Head-to-Head

Bigger by revenue
SEZL
SEZL
1.7× larger
SEZL
$78.2M
$45.1M
AMRN
Growing faster (revenue YoY)
SEZL
SEZL
+54.6% gap
SEZL
61.6%
7.0%
AMRN
Higher net margin
SEZL
SEZL
77.9% more per $
SEZL
54.6%
-23.3%
AMRN
Faster 2-yr revenue CAGR
SEZL
SEZL
Annualised
SEZL
76.0%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
SEZL
SEZL
Revenue
$45.1M
$78.2M
Net Profit
$-10.5M
$42.7M
Gross Margin
Operating Margin
35.5%
70.6%
Net Margin
-23.3%
54.6%
Revenue YoY
7.0%
61.6%
Net Profit YoY
33.0%
68.3%
EPS (diluted)
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
SEZL
SEZL
Q1 26
$45.1M
Q4 25
$49.2M
$78.2M
Q3 25
$49.7M
$57.5M
Q2 25
$72.7M
$52.0M
Q1 25
$42.0M
$48.2M
Q4 24
$62.3M
$48.4M
Q3 24
$42.3M
$35.6M
Q2 24
$67.5M
$30.2M
Net Profit
AMRN
AMRN
SEZL
SEZL
Q1 26
$-10.5M
Q4 25
$-1.2M
$42.7M
Q3 25
$-7.7M
$26.7M
Q2 25
$-14.1M
$27.6M
Q1 25
$-15.7M
$36.2M
Q4 24
$-48.6M
$25.4M
Q3 24
$-25.1M
$15.4M
Q2 24
$1.5M
$29.7M
Gross Margin
AMRN
AMRN
SEZL
SEZL
Q1 26
Q4 25
47.1%
Q3 25
44.7%
Q2 25
69.2%
Q1 25
59.8%
Q4 24
-15.4%
Q3 24
38.5%
Q2 24
63.4%
Operating Margin
AMRN
AMRN
SEZL
SEZL
Q1 26
35.5%
Q4 25
-12.9%
70.6%
Q3 25
-22.4%
61.9%
Q2 25
-22.0%
69.4%
Q1 25
-39.9%
Q4 24
-84.3%
63.8%
Q3 24
-59.5%
58.6%
Q2 24
-0.8%
55.3%
Net Margin
AMRN
AMRN
SEZL
SEZL
Q1 26
-23.3%
Q4 25
-2.5%
54.6%
Q3 25
-15.6%
46.4%
Q2 25
-19.4%
53.1%
Q1 25
-37.4%
75.1%
Q4 24
-78.0%
52.4%
Q3 24
-59.4%
43.4%
Q2 24
2.3%
98.4%
EPS (diluted)
AMRN
AMRN
SEZL
SEZL
Q1 26
Q4 25
$0.00
$1.19
Q3 25
$-0.02
$0.75
Q2 25
$-0.03
$0.78
Q1 25
$-0.04
$1.00
Q4 24
$-0.12
$0.71
Q3 24
$-0.06
$0.44
Q2 24
$0.00
$0.82

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
SEZL
SEZL
Cash + ST InvestmentsLiquidity on hand
$307.8M
$64.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$169.8M
Total Assets
$645.8M
$400.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
SEZL
SEZL
Q1 26
$307.8M
Q4 25
$302.6M
$64.1M
Q3 25
$286.6M
$104.1M
Q2 25
$298.7M
$88.9M
Q1 25
$281.8M
$88.9M
Q4 24
$294.2M
$73.2M
Q3 24
$305.7M
$80.1M
Q2 24
$306.7M
$58.0M
Stockholders' Equity
AMRN
AMRN
SEZL
SEZL
Q1 26
Q4 25
$459.3M
$169.8M
Q3 25
$458.9M
$155.3M
Q2 25
$464.9M
$130.4M
Q1 25
$473.7M
$125.8M
Q4 24
$486.2M
$87.8M
Q3 24
$531.4M
$61.1M
Q2 24
$551.9M
$50.3M
Total Assets
AMRN
AMRN
SEZL
SEZL
Q1 26
$645.8M
Q4 25
$670.8M
$400.2M
Q3 25
$659.8M
$367.0M
Q2 25
$670.1M
$350.6M
Q1 25
$655.7M
$298.1M
Q4 24
$685.3M
$298.4M
Q3 24
$750.6M
$252.9M
Q2 24
$799.9M
$212.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
SEZL
SEZL
Operating Cash FlowLast quarter
$70.6M
Free Cash FlowOCF − Capex
$70.6M
FCF MarginFCF / Revenue
90.2%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$209.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
SEZL
SEZL
Q1 26
Q4 25
$15.3M
$70.6M
Q3 25
$-12.7M
$63.7M
Q2 25
$16.6M
$23.1M
Q1 25
$-12.5M
$52.5M
Q4 24
$-13.3M
$57.4M
Q3 24
$-2.4M
$35.1M
Q2 24
$-2.7M
$22.2M
Free Cash Flow
AMRN
AMRN
SEZL
SEZL
Q1 26
Q4 25
$70.6M
Q3 25
$63.6M
Q2 25
$22.7M
Q1 25
$52.5M
Q4 24
$57.4M
Q3 24
$35.1M
Q2 24
$22.2M
FCF Margin
AMRN
AMRN
SEZL
SEZL
Q1 26
Q4 25
90.2%
Q3 25
110.6%
Q2 25
43.6%
Q1 25
108.9%
Q4 24
118.5%
Q3 24
98.6%
Q2 24
73.4%
Capex Intensity
AMRN
AMRN
SEZL
SEZL
Q1 26
Q4 25
0.1%
Q3 25
0.3%
Q2 25
0.8%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.1%
Cash Conversion
AMRN
AMRN
SEZL
SEZL
Q1 26
Q4 25
1.65×
Q3 25
2.39×
Q2 25
0.84×
Q1 25
1.45×
Q4 24
2.26×
Q3 24
2.27×
Q2 24
-1.81×
0.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

SEZL
SEZL

Merchant And Partner Income$28.9M37%
Transaction Income$25.9M33%
Income From Other Services Late Payment Fees$20.5M26%
Other$2.9M4%

Related Comparisons